ImClone News
Most Popular ImClone Story
Pfizer kills off Exubera, hunts for deals
It's official: Pfizer is giving up on Exubera. Pulling its plug cost the company $2.8... Read more...
Latest Headlines
- February 16, 2010
- July 20, 2009
- March 3, 2009
- January 13, 2009
- December 11, 2008
- December 9, 2008
- October 28, 2008
- October 15, 2008
- October 7, 2008
- October 6, 2008
- October 1, 2008
- October 1, 2008
- September 29, 2008
- September 26, 2008
- September 24, 2008
- September 23, 2008
- September 16, 2008
- September 16, 2008
- September 12, 2008
- September 11, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
